桂枝茯苓丸联合米非司酮治疗子宫肌瘤的效果及对激素水平和血液流变学的影响

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo study the effect of GuizhiFuling Pills combined with Mifepristone in the treatment of hysteromyoma and its influence on hormone levels and hemorheology.MethodsFrom August 2015 to August 2016,100 patients with uterine fibroids treated in our hospital were selected and evenly divided into experimental group and control group according to the simple randomization.In the experimental group,patients were treated with Mifepristone combined with GuizhiFuling Pills.In the control group,only Mifepristone was used.The therapeutic effect after 3-month courses of treatment was compared.Besides,the average size of uterine fibroids,the change of hormone levels,and the change of hemorheology in the two groups before and after treatment were compared.ResultsAfter therapy,the total effective rate was 92.0%in the experimental group,much higher than that in the control group(78.0%),the difference was statistically significant(P＜0.05);the size of uterine fibroids after therapy in the experimental group was smaller than that in the control group (P＜0.05).The indexes of blood viscosity,plasmaviscosity,hematocrit and platelet aggregation rate were significantly lower after therapy compared with those before treatment,and those indexes in the experimental group were greatly lower than the control group,the differences were statistically significant(P＜0.05).ConclusionCombination of GuizhiFuling Pills and Mifepristone can obtain an optimal effect on treating uterine fibroids.It reduces the size of hysteromyoma,decreases the levels of LH,FSH,P,and E2,as well as the hemodynamic indexes including blood viscosity,plasmaviscosity,hematocrit and platelet aggregation rate,which is worthy of clinical promotion.

Key words： GuizhiFuling Pills Mifepristone Uterinefibroids Effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIE Xiao-hong

Cite this article:

XIE Xiao-hong. Effect of GuizhiFuling Pills combined with Mifepristone on hysteromyoma and its influence on hormone level and hemorheology[J]. 中国当代医药, 2017, 24(20): 103-105.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I20/103

[1]	徐爱玲.米司非酮联合桂枝茯苓丸治疗子宫肌瘤的临床效果分析[J].中国民族民间医药，2013，22（2）：59-60.
[2]	张武芳，李冬华，韩虹娟，等.子宫肌瘤的病因学研究进展[J].现代中西医结合杂志，2015，24（2）：216-219.
[3]	白慧萍.桂枝茯苓丸胶囊配合米非司酮对子宫肌瘤患者肌瘤体积、血红蛋白及其临床症状的影响[J].陕西中医，2014，35（10）：1366-1368.
[4]	张妙兰.米非司酮配伍与不配伍桂枝茯苓丸治疗子宫肌瘤的临床观察[J].中外妇儿健康，2014，（9）：229-230.
[5]	姚彬，朱艳，张慧君，等.桂枝茯苓胶囊联合米非司酮治疗子宫腺肌病的临床疗效[J].西部中医药，2015，28（1）：75-77.
[6]	雷晓娟.米非司酮合并桂枝茯苓丸治疗子宫肌瘤的临床治疗体会[J].中国医药指南，2015，13（22）：56-57.
[7]	黄婉琼.桂枝茯苓丸联合米非司酮治疗子宫肌瘤的疗效研究[J].中医临床研究，2015，7（33）：62-63.
[8]	魏平.桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤43例[J].西部中医药，2014，27（10）：116-117.
[9]	李莉.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤患者的临床效果及预后分析[J].中国实用医药，2016，22（2）：140-141.
[10]	李丽.不同剂量米非司酮治疗子宫肌瘤效果比较[J].山东医药，2015，10（23）：94-95.
[11]	苏爱丽.中药治疗子宫肌瘤的疗效分析[J].临床合理用药杂志，2014，7（22）：48.
[12]	蒋志滨，于蓓蓓，华浩明，等.桂枝茯苓胶囊联合米非司酮治疗子宫肌瘤疗效的 Meta 分析[J].中成药，2013，1（2）：36-40，67.
[13]	沈秀妹，唐婷玉.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤的疗效观察[J].中国现代医生，2013，51（8）：83-85.
[14]	李笠，高树苓.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤患者的疗效分析[J].中国肿瘤临床与康复，2015，22（1）：62-65.
[15]	李天华，张亚琴，张英华.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤疗效观察[J].现代中西医结合杂志，2012，21（2）：162-163.
[16]	张文华.对34例使用桂枝茯苓胶囊治疗子宫肌瘤患者的临床观察[J].求医问药（下半月），2015，9（10）：202.
[17]	刘丽霞，管利.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤的疗效观察[J].中国医院用药评价与分析，2016，16（7）：946-948.
[18]	季华.米非司酮联合桂枝茯苓胶囊治疗子宫肌瘤患者的临床探讨[J].中国医药导刊，2014，16（5）：864，866.